MIC-based dose adjustment: facts and fables

Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy

(2017) Caleb J.P. Economou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France

(2016) A. Charmillon et al.   CLINICAL MICROBIOLOGY AND INFECTION

Therapeutic drug monitoring of anti-infective agents in critically ill patients

(2016) Nynke G. L. Jager et al.   Expert Review of Clinical Pharmacology

The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?

(2015) Gunnar Kahlmeter   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica

(2015) Robert Skov et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development

(2015) Mohd Abdul-Aziz et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units

(2014) G. Wong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Augmented Renal Clearance

(2009) Andrew A. Udy et al.   CLINICAL PHARMACOKINETICS

Evaluation of Quinolones for Use in Detection of Determinants of Acquired Quinolone Resistance, Including the New Transmissible Resistance Mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and Determinations of Wild-Type Distributions

(2009) L. M. Cavaco et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cephalosporin MIC Distribution of Extended-Spectrum- -Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species

(2009) P. C. Kohner et al.   JOURNAL OF CLINICAL MICROBIOLOGY